Literature DB >> 27318466

Effects of doxorubicin administration on bone strength and quality in sedentary and physically active Wistar rats.

H Fonseca1, A Carvalho2, J Esteves3, V I Esteves4, D Moreira-Gonçalves2,5, J A Duarte2.   

Abstract

Doxorubicin (DOX) is used in pediatric cancer treatment. This study assessed the effects of 7 weeks of DOX and 10-week recovery on bone quality and biomechanical properties in sedentary and exercised Wistar rats. DOX decreases femur diaphysis radial growth and biomechanical properties. Some of these DOX effects were aggravated by exercise.
INTRODUCTION: Bone growth in pre-pubertal years critically influences adult fracture risk. DOX is widely used in the treatment of pediatric cancers, but there is limited evidence on its potential negative effects on bone growth. Exercise improves bone growth in children, but there is no evidence if it protects against DOX-induced bone toxicity. This study investigates the early and intermediate effects of a 7-week course of DOX on bone histomorphometry and strength in sedentary and exercised growing animal models.
METHODS: Sixty-eight male Wistar rats (8 weeks) were treated with DOX (2 mg kg-1) or vehicle for 7 weeks and afterward housed in standard cages or in cages with a running wheel and killed 2 or 10 weeks after last DOX administration. Femurs and blood were collected for assaying geometry, trabecular microarchitecture (histology), biomechanical properties (three-point bending and shearing of the femoral neck), bone calcium content and density (atomic absorption spectroscopy), and bone turnover markers (ELISA).
RESULTS: DOX treatment reduced the femur diaphysis radial growth, with DOX-treated animals having a lower tissue area, cortical area, cortical thickness, and moment of inertia. DOX also decreased distal femur trabecular bone volume and trabecular number and increased trabecular separation. Femur diaphysis stiffness and maximum load were also reduced in past DOX-treated animals. Exercise was shown to worsen the effects of past DOX treatment on the femur diaphysis mechanical properties.
CONCLUSION: DOX negatively affects bone geometry, trabecular microarchitecture, and femur mechanical properties in growing Wistar rats. Exercise further aggravates the detrimental effects of past DOX treatment on bone mechanical properties.

Entities:  

Keywords:  Adriamycin; Bone fracture; Cancer; Chemotherapy; Exercise

Mesh:

Substances:

Year:  2016        PMID: 27318466     DOI: 10.1007/s00198-016-3672-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

1.  Construction of the femoral neck during growth determines its strength in old age.

Authors:  Roger M D Zebaze; Anthony Jones; Mark Knackstedt; Ghassan Maalouf; Ego Seeman
Journal:  J Bone Miner Res       Date:  2007-07       Impact factor: 6.741

Review 2.  The osteocyte lineage.

Authors:  Brendon S Noble
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

3.  Voluntary exercise has long-term in vivo protective effects on osteocyte viability and bone strength following ovariectomy.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; José Luís Soares Esteves; Nuno Viriato; Mário Vaz; Maria Paula Mota; José Alberto Duarte
Journal:  Calcif Tissue Int       Date:  2011-03-18       Impact factor: 4.333

Review 4.  Basic biomechanical measurements of bone: a tutorial.

Authors:  C H Turner; D B Burr
Journal:  Bone       Date:  1993 Jul-Aug       Impact factor: 4.398

5.  Increased intracortical remodeling following fatigue damage.

Authors:  S Mori; D B Burr
Journal:  Bone       Date:  1993 Mar-Apr       Impact factor: 4.398

6.  Bone remodeling in response to in vivo fatigue microdamage.

Authors:  D B Burr; R B Martin; M B Schaffler; E L Radin
Journal:  J Biomech       Date:  1985       Impact factor: 2.712

7.  Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.

Authors:  Anna L Schwartz; Kerri Winters-Stone; Betty Gallucci
Journal:  Oncol Nurs Forum       Date:  2007-05       Impact factor: 2.172

8.  Oxidative destruction of DNA by the adriamycin-iron complex.

Authors:  H Eliot; L Gianni; C Myers
Journal:  Biochemistry       Date:  1984-02-28       Impact factor: 3.162

9.  Growth from birth to adulthood and peak bone mass and density data from the New Delhi Birth Cohort.

Authors:  N Tandon; C H D Fall; C Osmond; H P S Sachdev; D Prabhakaran; L Ramakrishnan; S K Dey Biswas; S Ramji; A Khalil; T Gera; K S Reddy; D J P Barker; C Cooper; S K Bhargava
Journal:  Osteoporos Int       Date:  2012-01-12       Impact factor: 4.507

10.  Evaluation of bone toxicity in various bones of aged rats.

Authors:  Chihiro Noguchi; Hiroto Miyata; Yasushi Sato; Yoshinobu Iwaki; Shigeru Okuyama
Journal:  J Toxicol Pathol       Date:  2011-03-31       Impact factor: 1.628

View more
  7 in total

1.  Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease.

Authors:  Joseph P Vanderburgh; Kristin A Kwakwa; Thomas A Werfel; Alyssa R Merkel; Mukesh K Gupta; Rachelle W Johnson; Scott A Guelcher; Craig L Duvall; Julie A Rhoades
Journal:  J Control Release       Date:  2019-09-05       Impact factor: 9.776

2.  ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.

Authors:  Rafael Barreto; Yukiko Kitase; Tsutomu Matsumoto; Fabrizio Pin; Kyra C Colston; Katherine E Couch; Thomas M O'Connell; Marion E Couch; Lynda F Bonewald; Andrea Bonetto
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

3.  Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models.

Authors:  Chia-Ying Lien; Chen-Wen Lu; Yi-Hsuan Lin; Wan-Jhen Wu; Chih-Hsiang Hsu; Tai-Yuan Chuang; Kuei-Fu Lin; Wu-Chang Chuang; Ming-Chung Lee; Chung-Hsin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-05       Impact factor: 2.629

4.  Doxorubicin Induces Bone Loss by Increasing Autophagy through a Mitochondrial ROS/TRPML1/TFEB Axis in Osteoclasts.

Authors:  Hyun-Jung Park; Sun-Young Yoon; Jung-Nam Park; Jae-Hee Suh; Hye-Seon Choi
Journal:  Antioxidants (Basel)       Date:  2022-07-28

5.  Association between Visceral and Bone Marrow Adipose Tissue and Bone Quality in Sedentary and Physically Active Ovariectomized Wistar Rats.

Authors:  Hélder Fonseca; Andrea Bezerra; Ana Coelho; José Alberto Duarte
Journal:  Life (Basel)       Date:  2021-05-25

6.  Is There an Association Between Bone Microarchitecture and Fracture in Patients who were Treated for High-grade Osteosarcoma? A Controlled Study at Long-term Follow-up Using High-resolution Peripheral Quantitative CT.

Authors:  Gerold Holzer; Gerhard Hobusch; Stinus Hansen; Lukas Fischer; Janina M Patsch
Journal:  Clin Orthop Relat Res       Date:  2021-11-01       Impact factor: 4.755

7.  Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.

Authors:  Chia-Ming Fan; Yu-Wen Su; Peter R Howe; Cory J Xian
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.